URIST MARSHALL (EVP & Co-Head Research & Inv.) sold 61.9% of their position (41.58K shares) of ROYALTY PHARMA PLC on the open market
Open‑market sale worth $1.66M — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 12/3/2025ACC: 0001838139-25-000006
Officer· EVP & Co-Head Research & Inv.
Since Dec 2020
-41.58K
Net shares
Net seller
$1.66M
Total sold
2
Open market trades
0B · 2S
2
Total transactions
41.58K disposed
Non-Derivative Transactions2
Class A Ordinary Shares
Indirect
Shares
−23.33K
Price / share
$39.93
Trade value
$931.63K
% of position
11.3%
12/1/2025
206.67K→183.33K
Class A Ordinary Shares
Direct
Shares
−18.24K
Price / share
$39.90
Trade value
$727.86K
% of position
41.6%
12/1/2025
43.88K→25.64K
Total
Net shares
−41.58K
Net value
-$1.66M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Class A Ordinary Shares Indirect | 12/1/2025 | S · Sale | −23.33K | $39.93 | $931.63K | 11.3% | 206.67K | 183.33K |
| Class A Ordinary Shares Direct | 12/1/2025 | S · Sale | −18.24K | $39.90 | $727.86K | 41.6% | 43.88K | 25.64K |
| Total | −41.58K | -$1.66M | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Class A Ordinary Shares
IndirectShares owned19.02K
Total
19.02K indirect19.02K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Class A Ordinary Shares | 19.02K | Indirect |
| Total | 19.02K | 19.02K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported